A word from the CEO
ALKOS Group was restructured recently and now gathers INTER Cosmétiques, ALKOS Cosmétiques and SAGAL Cosmétiques under its name to serve actors of the Cosmetics Industry. Our turnover has increased by 40% between 2012 and 2015: this is the result of our clients’ trust and combined efforts of sales and production teams, working together on a common project.
Our mission is to continue developing our Group by becoming a major partner for Full-Service projects, as well as strengthen and assert our significant position in the fields of makeup, skincare and hygiene.
I am convinced that our goals shall be reached if we remain faithful to our managerial principles :
- combine the talents and energies of women and men working at ALKOS Group, to attract new ones and retain their expertise by implementing quality management promoting professional development and the pleasure of working together.
- stick to our values include sharing, trust, communication, solidarity and passion.
Thanks to our shareholders’ investments and supports, we are able to offer innovative, quality products with a high level of service to our clients. We care to create a relationship based on exchange of ideas and trust : « We can say anything we like as long as it is well said ».
Dominique VAUTIER, ALKOS Group CEO, AAXEN President
Nicolas Jacques CONTE invented the process of encasing graphite leads in a wooden cylinder.
CONTE Cosmétiques is part of BIC Group.
Creation of INTERCOSMETIQUES (Skincare & Makeup) in Angers (13 people).
Purchase by Mr. G. Gieux and new ALKOS Cosmétiques identity (Boulogne-sur-Mer).
Purchase of SAGAL (soaps & sticks) in Chartres, created in 1981 by Chanel, Dior & Guerlain.
Purchase of both INTERCOSMETIQUES & SAGAL by ALKOS Développement.
New Top management & New Strategy.
ALKOS Group & COSMOGEN have merged into the same Holding AAXEN. MBO majority shareholder 51% and private historical shareholder Mr. G. Gieux.
Mr. D. Vautier is named President of the Holding.
New visual identity, international development goals.